18F-OP-801
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-OP-801, covering 2025-05-02 to 2025-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers [Phase 1, Phase 2]